(Q48030178)

7 February 2018

title

Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. (English)

1 reference

7 February 2018

0 references

Yoshihiko Seino

1

1 reference

7 February 2018

Akio Ogawa

2

1 reference

7 February 2018

Teruyo Yamashita

3

1 reference

7 February 2018

Masato Fukushima

4

1 reference

7 February 2018

Ken-ichi Ogata

5

1 reference

7 February 2018

Hiroko Fukumoto

6

1 reference

7 February 2018

Teruo Takano

7

1 reference

7 February 2018

publication date

1 March 2004

1 reference

7 February 2018

European Journal of Heart Failure

published in

1 reference

7 February 2018

volume

6

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

295-300

1 reference

7 February 2018

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Pathophysiological analysis of serum troponin T release kinetics in evolving ischemic myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: Endocrinologic silence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.12.009

10.1016/J.EJHEART.2003.12.009

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

14987579

1 reference

7 February 2018